Delaying the onset of experimental autoimmune encephalomyelitis with the microtubule-stabilizing compounds, paclitaxel and Peloruside A

Journal of Leukocyte Biology

Volumn 86, Issue 4, 2009, Pages 949-958

  Crume, Kevin P ^a   O'Sullivan, David ^a   Miller, John H ^a   Northcote, Peter T ^a   La Flamme, Anne C ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Antimitotic drugs; Autoimmunity; Multiple sclerosis

Indexed keywords

ANTIMITOTIC AGENT; DOCETAXEL; PACLITAXEL; PELORUSIDE A; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TARGET CELL; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL DIVISION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; G2 PHASE; LACTONES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROTUBULES; MULTIPLE SCLEROSIS; PACLITAXEL; T-LYMPHOCYTES; TIME FACTORS; TUBULIN MODULATORS;

ANIMALIA; MUS;

EID: 70349646802     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0908541     Document Type: Article

References (45)

1. Chuang, L. T., Lotzova, E., Heath, J., Cook, K. R., Munkarah, A., Morris, M., Wharton, J. T. (1994) Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res. 54, 1286-1291. (Pubitemid 24108070)
2. Brown, D. L., Little, J. E., Chaly, N., Schweitzer, I., Paulin-Levasseur, M. (1985) Effects of taxol on microtubule organization in mouse splenic lymphocytes and on response to mitogenic stimulation. Eur. J. Cell Biol. 37, 130-139. (Pubitemid 15054922)
3. Crume, K. P., Miller, J. H., La Flamme, A. C. (2007) Peloruside A, an antimitotic agent, specifically decreases tumor necrosis factor-α production by lipopolysaccharide-stimulated murine macrophages. Exp. Biol. Med. (Maywood) 232, 607-613.
4. Ridge, S. C., Sloboda, A. E., McReynolds, R. A., Levine, S., Oronsky, A. L., Kerwar, S. S. (1985) Suppression of experimental allergic encephalomyelitis by mitoxantrone. Clin. Immunol. Immunopathol. 35, 35-42. (Pubitemid 15115469)
5. Cavaletti, G., Cavalletti, E., Crippa, L., Di Luccio, E., Oggioni, N., Mazzanti, B., Biagioli, T., Sala, F., Sala, V., Frigo, M., Rota, S., Tagliabue, E., Stanzani, L., Galbiati, S., Rigolio, R., Zoia, C., Tredici, G., Perseghin, P., Dassi, M., Riccio, P., Lolli, F. (2004) Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 151, 55-65. (Pubitemid 38624400)
6. Schiff, P. B., Fant, J., Horwitz, S. B. (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277, 665-667. (Pubitemid 9114288)
7. Schiff, P. B., Horwitz, S. B. (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77, 1561-1565.
8. Xiao, H., Verdier-Pinard, P., Fernandez-Fuentes, N., Burd, B., Angeletti, R., Fiser, A., Horwitz, S. B., Orr, G. A. (2006) Insights into the mechanism of microtubule stabilization by Taxol. Proc. Natl. Acad. Sci. USA 103, 10166-10173. (Pubitemid 44051138)
9. Gligorov, J., Lotz, J. P. (2004) Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 9 (Suppl. 2), 3-8. (Pubitemid 38747838)
10. Bhalla, K. N. (2003) Microtubule-targeted anticancer agents and apoptosis. Oncogene 22, 9075-9086.
11. Knox, J. D., Mitchel, R. E., Brown, D. L. (1993) Effects of taxol and taxol/hyperthermia treatments on the functional polarization of cytotoxic T lymphocytes. Cell Motil. Cytoskeleton 24, 129-138.
12. Byrd-Leifer, C. A., Block, E. F., Takeda, K., Akira, S., Ding, A. (2001) The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur. J. Immunol. 31, 2448-2457. (Pubitemid 32785364)
13. Cao, L., Sun, D., Cruz, T., Moscarello, M. A., Ludwin, S. K., Whitaker, J. N. (2000) Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel. J. Neuroimmunol. 108, 103-111. (Pubitemid 30438757)
14. Brahn, E., Tang, C., Banquerigo, M. L. (1994) Regression of collagen-induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum. 37, 839-845. (Pubitemid 24184535)
15. Fitzpatrick, F. A., Wheeler, R. (2003) The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents. Int. Immunopharmacol. 3, 1699-1714. (Pubitemid 37421260)
16. Sako, T., Burioka, N., Yasuda, K., Tomita, K., Miyata, M., Kurai, J., Chikumi, H., Watanabe, M., Suyama, H., Fukuoka, Y., Ueda, Y., Shimizu, E. (2004) Cellular immune profile in patients with non-small cell lung cancer after weekly paclitaxel therapy. Acta Oncol. 43, 15-19. (Pubitemid 38283168)
17. Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. (2002) Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer 87, 21-27. (Pubitemid 34888597)
18. West, L. M. N., Northcote, P. T., Battershill, C. N. (2000) Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp. J. Org. Chem. 65, 445-449. (Pubitemid 30061125)
19. Hood, K. A., West, L. M., Rouwé, B., Northcote, P. T., Berridge, M. V., Wakefield, St. J., Miller, J. H. (2002) Peloruside, a novel anti-mitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Res. 62, 3356-3360. (Pubitemid 34651377)
20. Hood, K. A., Bäckström, B. T., West, L. M., Northcote, P. T., Berridge, M. V., Miller, J. H. (2001) The novel cytotoxic sponge metabolite Peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C. Anticancer Drug Des. 16, 155-166.
21. Miller, J. H., Rouwé, B., Gaitanos, T. N., Hood, K. A., Crume, K. P., Bäckström, B. T., La Flamme, A. C., Berridge, M. V., Northcote, P. T. (2004) Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells. Apoptosis 9, 785-796.
22. Gaitanos, T. N., Buey, R. M., Díaz, J. F., Northcote, P. T., Teesdale-Spittle, P., Andreu, J. M., Miller, J. H. (2004) Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res. 64, 5063-5067. (Pubitemid 39006519)
23. Wilmes, A., Bargh, K., Kelly, C., Northcote, P. T., Miller, J. H. (2007) Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines. Mol. Pharmaceut. 4, 269-280. (Pubitemid 46640603)
24. Kuchroo, V. K., Weiner, H. L. (1998) Antigen-driven regulation of experimental autoimmune encephalomyelitis. Res. Immunol. 149, 759-771.
25. Kuchroo, V. K., Sobel, R. A., Laning, J. C., Martin, C. A., Greenfield, E., Dorf, M. E., Lees, M. B. (1992) Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V β usage. J. Immunol. 148, 3776-3782.
26. Miller, S. D., Shevach, E. M. (1998) Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview. Res. Immunol. 149, 753-759.
27. Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., Kuchroo, V. K. (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073-1081. (Pubitemid 36570063)
28. Brunet, L. R., Finkelman, F. D., Cheever, A. W., Kopf, M. A., Pearce, E. J. (1997) IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159, 777-785.
29. La Flamme, A. C., Pearce, E. J. (1999) The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses. J. Immunol. 162, 5829-5837.
30. La Flamme, A. C., Harvie, M., McNeill, A., Goldsack, L., Tierney, J. B., Bäckström, B. T. (2006) Fcγ receptor-ligating complexes improve the course of experimental autoimmune encephalomyelitis by enhancing basal Th2 responses. Immunol. Cell Biol. 84, 522-529. (Pubitemid 44657024)
31. Bissery, M. C., Nohynek, G., Sanderink, G. J., Lavelle, F. (1995) Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: preclinical experience. Anticancer Drugs 6, 339-355.
32. Meyer, C., Ferguson, D., Krauth, M., Wick, M., Northcote, P. T. (2006) RTA 301 (peloruside): a novel microtubule stabilizer with potent in vivo activity against lung cancer and resistant breast cancer. Eur. J. Cancer 4, (Suppl.), 192.
33. Elliott, J. I., Raguz, S., Higgins, C. F. (2004) Multidrug transporter activity in lymphocytes. Br. J. Pharmacol. 143, 899-907.
34. Targoni, O. S., Baus, J., Hofstetter, H. H., Hesse, M. D., Karulin, A. Y., Boehm, B. O., Forsthuber, T. G., Lehmann, P. V. (2001) Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J. Immunol. 166, 4757-4764. (Pubitemid 32233765)
35. Angiotech Pharmaceuticals. (2002) Micellar paclitaxel does not appear to be effective in patients with multiple sclerosis. Inpharma Weekly 1328, 11.
36. Ding, A., Sanchez, E., Nathan, C. F. (1993) Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J. Immunol. 151, 5596-5602. (Pubitemid 23332369)
37. Kawasaki, K., Akashi, S., Shimazu, R., Yoshida, T., Miyake, K., Nishijima, M. (2000) Mouse Toll-like receptor 4.MD-2 complex mediates lipopolysaccharidemimetic signal transduction by Taxol. J. Biol. Chem. 275, 2251-2254. (Pubitemid 30081977)
38. Manthey, C. L., Qureshi, N., Stutz, P. L., Vogel, S. N. (1993) Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J. Exp. Med. 178, 695-702. (Pubitemid 23218219)
39. Maher, J. M., Slitt, A. L., Cherrington, N. J., Cheng, X., Klaassen, C. D. (2005) Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab. Dispos. 33, 947-955. (Pubitemid 41002776)
40. Richaud-Patin, Y., Soto-Vega, E., Jakez-Ocampo, J., Llorente, L. (2004) P-glycoprotein in autoimmune diseases. Autoimmun. Rev. 3, 188-192.
41. Neal, R. A., van Bueren, J., McCoy, N. G., Iwobi, M. (1989) Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil. Trans. R. Soc. Trop. Med. Hyg. 83, 197-198. (Pubitemid 19265563)
42. Nakashima, H., Tasaki, A., Kubo, M., Kuroki, H., Matsumoto, K., Tanaka, M., Nakamura, M., Morisaki, T., Katano, M. (2005) Effects of docetaxel on antigen presentation-related functions of human monocyte-derived dendritic cells. Cancer Chemother. Pharmacol. 55, 479-487. (Pubitemid 40568979)
43. Peachman, K. K., Rao, M., Palmer, D. R., Zidanic, M., Sun, W., Alving, C. R., Rothwell, S. W. (2004) Functional microtubules are required for antigen processing by macrophages and dendritic cells. Immunol. Lett. 95, 13-24. (Pubitemid 39119895)
44. Feldmann, M., Brennan, F. M., Maini, R. N. (1996) Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14, 397-440.
45. Feldmann, M. (2002) Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol. 2, 364-371. (Pubitemid 37328759)